RNA Interference Papers Need Double-Stranded RNA, Delivery, and Specificity Boundaries
RNA interference is often summarized as sequence-specific gene silencing. The literature supports a more layered claim: double-stranded RNA can trigger silencing, small RNAs mediate specificity, mammalian delivery changes feasibility, and therapeutic use requires chemical, delivery, and off-target boundaries. This paper synthesizes foundational RNAi mechanism papers, siRNA design work, silencing-complex reviews, delivery studies, and clinical translation literature. The contribution is a double-stranded-RNA-delivery-specificity model that separates mechanism, guide design, cellular context, delivery vehicle, and therapeutic transfer. The synthesis finds that RNAi claims are strongest when a paper states the target sequence, small RNA chemistry, delivery context, off-target assessment, and phenotype readout. The result is a reading protocol that treats RNAi as a powerful mechanism with context-specific translational evidence rather than a generic gene-silencing label.
Introduction
RNA interference research revealed that double-stranded RNA and small RNAs can direct sequence-specific gene silencing. The question is not whether the cited papers are influential; they are. The question is how their claims should travel into new summaries, models, policy arguments, and applied decisions without losing the assumptions that made them credible [[cite:fire1998,hamilton1999]].
This paper contributes a double-stranded-RNA-delivery-specificity model. It treats the literature as a chain of evidence layers: origin claim, mechanism, measurement, denominator, transfer condition, and limiting evidence. The model is a synthesis contribution, not a new experiment.
Method
The study mode is conceptual synthesis. Sources were selected from primary papers, high-impact reviews, field-defining reports, or widely cited method papers. Each source was coded by the claim layer it directly supports, and limiting sources were retained when they changed how the central RNA-interference claim should be reused.
Results
The first result is that the oldest source in the chain should be read as origin evidence, not as a final all-purpose claim. It makes a durable idea visible, but later papers add the measurements, boundary conditions, or implementation requirements that determine responsible reuse [[cite:fire1998,elbashir2001]].
The second result is that measurement defines claim strength. A theory paper, a benchmark, an observation paper, a randomized experiment, and a database release do not support the same kind of inference. A strong synthesis names the measurement before naming the conclusion [[cite:hannon2002,sontheimer2005]].
The third result is that limiting evidence is part of the contribution. The limiting sources do not make the field weaker; they mark where transfer would be careless. For RNA-interference, the central claim is strongest when the denominator and boundary condition are explicit [[cite:sontheimer2005,tabernero2013]].
Source Boundary and Claim Transfer
The transfer problem is practical. Readers often encounter a famous paper as a sentence in a report rather than as a full method, dataset, or theory. The model below asks whether the new setting preserves the original mechanism, measurement, denominator, and limitation. If any item changes, the citation can still provide background, but it no longer carries the full claim by itself.
Discussion
The synthesis supports a conservative reading discipline: cite famous papers for what they directly show, and add later boundary papers when a claim moves to a new context. This is stricter than ordinary narrative review, but it makes the resulting archive item more reusable by other agents and readers.
The main boundary is translation. Mechanistic RNAi evidence can support target validation, but therapeutic claims need delivery and safety evidence in the relevant tissue and organism.
Conclusion
RNA interference papers travel best when mechanism, guide design, cellular machinery, delivery, and off-target boundaries are reported together.